<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical features and genetics of Charcot-Marie-Tooth (CMT) disease types 1, 2, X, 3, and 4</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical features and genetics of Charcot-Marie-Tooth (CMT) disease types 1, 2, X, 3, and 4</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clinical features and genetics of Charcot-Marie-Tooth (CMT) disease types 1, 2, X, 3, and 4</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="20%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Disorder</td> <td class="subtitle1">Gene</td> <td class="subtitle1">Locus</td> <td class="subtitle1">Clinical features</td> </tr> <tr> <td colspan="3"><strong>CMT1</strong></td> <td> <ul> <li>Onset in first or second decade </li> </ul> </td> </tr> <tr> <td class="indent1">CMT1A</td> <td><em>PMP22</em></td> <td>17p12</td> <td rowspan="6"> <ul> <li>Motor symptoms predominate (clumsy walking) </li> <li>Gradual loss of proprioception and vibration </li> <li>Ambulation usually maintained </li> <li>Normal life expectancy </li> <li>Palpable enlargement of the peripheral nerves </li> <li>NCV slowed to &lt;60% normal </li> </ul> </td> </tr> <tr> <td class="indent1">CMT1B</td> <td><em>MPZ</em></td> <td>1q23.3</td> </tr> <tr> <td class="indent1">CMT1C</td> <td><em>LITAF</em></td> <td>16p13.13</td> </tr> <tr> <td class="indent1">CMT1D</td> <td><em>EGR2</em></td> <td>10q21.3</td> </tr> <tr> <td class="indent1">CMT1E</td> <td><em>PMP22</em></td> <td>17p12</td> </tr> <tr> <td class="indent1">CMT1F</td> <td><em>NEFL</em></td> <td>8p21</td> </tr> <tr> <td class="indent1 divider_bottom" rowspan="2">Roussy-Levy</td> <td><em>MPZ</em></td> <td>1q23.3</td> <td class="divider_bottom" rowspan="2"> <ul> <li>CMT1 features plus: <ul> <li>Postural tremor and gait ataxia </li> </ul> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><em>PMP22</em></td> <td>17p12</td> </tr> <tr> <td colspan="3"><strong>CMT2</strong></td> <td> <ul> <li>Onset in second or third decade </li> </ul> </td> </tr> <tr> <td class="indent1">CMT2A</td> <td><em>MFN2</em></td> <td>1p36.2</td> <td rowspan="17"> <ul> <li>Sensory symptoms predominate </li> </ul> </td> </tr> <tr> <td class="indent1">CMT2B</td> <td><em>RAB7</em></td> <td>3q21.3</td> </tr> <tr> <td class="indent1">CMT2C</td> <td><em>TRPV4</em></td> <td>12q24.1</td> </tr> <tr> <td class="indent1">CMT2D</td> <td><em>GARS</em></td> <td>7p15</td> </tr> <tr> <td class="indent1">CMT2E</td> <td><em>NEFL</em></td> <td>8p</td> </tr> <tr> <td class="indent1">CMT2F</td> <td><em>HSPB1</em></td> <td>7q11.23</td> </tr> <tr> <td class="indent1">CMT2H</td> <td>Unknown</td> <td>8q13-q23</td> </tr> <tr> <td class="indent1">CMT2I/2J</td> <td><em>MPZ</em></td> <td>1q23.3</td> </tr> <tr> <td class="indent1">CMT2K</td> <td><em>GDAP1</em> (<em>JPH1</em> modifier)</td> <td>8q21.11</td> </tr> <tr> <td class="indent1">CMT2L</td> <td><em>HSPB8</em></td> <td>12q24.23</td> </tr> <tr> <td class="indent1">CMT2M</td> <td><em>DNM2</em></td> <td>19p13.2</td> </tr> <tr> <td class="indent1">CMT2N</td> <td><em>AARS1</em></td> <td>16q22.1</td> </tr> <tr> <td class="indent1">CMT2O</td> <td><em>DYNC1H1</em></td> <td>14q32.31</td> </tr> <tr> <td class="indent1">CMT2P</td> <td><em>LRSAM1</em></td> <td>9q33.3-q34.1</td> </tr> <tr> <td class="indent1">CMT2S</td> <td><em>IGHMBP2</em></td> <td>11q13.3</td> </tr> <tr> <td class="indent1">CMT2T</td> <td><em>MME</em></td> <td>3q25.2</td> </tr> <tr> <td class="indent1">CMT2U</td> <td><em>MARS1</em></td> <td>12q13.3</td> </tr> <tr class="divider_bottom"> <td class="indent1">Early onset</td> <td>Â </td> <td>Not known</td> <td> <ul> <li>Onset before age 5 years </li> <li>Rapid progression of weakness below the knee </li> <li>Loss of ambulation by mid-teens </li> <li>NCV normal or mildly reduced </li> </ul> </td> </tr> <tr> <td colspan="3"><strong>CMTX</strong></td> <td> <ul> <li>X-linked </li> </ul> </td> </tr> <tr> <td class="indent1">CMTX1</td> <td><em>GJB1</em></td> <td>Xq13.1</td> <td> <ul> <li>CMT1 features plus: <ul> <li>Symptoms more prominent in males </li> <li>Symptomatic in second decade </li> <li>Loss of ankle reflexes </li> <li>NCV moderately slowed </li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1">CMTX2</td> <td>Not known</td> <td>Xp22</td> <td> <ul> <li>Affects males only </li> <li>Infantile onset with risk of intellectual disability </li> <li>May have both axonal and demyelinating physiology </li> </ul> </td> </tr> <tr> <td class="indent1">CMTX3</td> <td>78kb insertion from chromosome 8</td> <td>Xq27.1</td> <td> <ul> <li>Affects males only </li> <li>Juvenile onset </li> <li>Prominent sensory symptoms </li> </ul> </td> </tr> <tr> <td class="indent1"> <p>CMTX4</p> (Cowchock syndrome) </td> <td><em>AIFM1</em></td> <td>Xq26</td> <td> <ul> <li>Affects primarily males, who have infantile onset axonal neuropathy with deafness and intellectual disability </li> <li>Females have mild symptoms </li> </ul> </td> </tr> <tr> <td class="indent1">CMTX5</td> <td><em>PRPS1</em></td> <td>Xq22.3</td> <td> <ul> <li>Affects males only </li> <li>Deafness and optic neuropathy </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">CMTX6</td> <td><em>PDK3</em></td> <td>Xp22.11</td> <td> <ul> <li>Affects primarily males </li> <li>Predominantly axonal sensorimotor polyneuropathy </li> </ul> </td> </tr> <tr> <td colspan="3"><strong>CMT3</strong></td> <td> <ul> <li>Severe, early onset </li> </ul> </td> </tr> <tr> <td class="indent1" rowspan="3">Dejerine-Sottas syndrome</td> <td><em>PMP22</em></td> <td>17p12</td> <td rowspan="3"> <ul> <li>Hypotonia in early infancy </li> <li>Delayed motor development </li> <li>Initial sensory loss and distal weakness </li> <li>Ataxia </li> <li>NCV profoundly slowed (10 m/second) </li> </ul> </td> </tr> <tr> <td><em>MPZ</em></td> <td>1q23.3</td> </tr> <tr> <td><em>EGR2</em></td> <td>10q21.3</td> </tr> <tr> <td class="indent1 divider_bottom" rowspan="3">Congenital hypomyelinating neuropathy</td> <td><em>PMP22</em></td> <td>17p12</td> <td class="divider_bottom" rowspan="3"> <ul> <li>Profound hypotonia and contractures at birth </li> <li>Feeding difficulties </li> <li>Respiratory distress </li> <li>Death in infancy </li> <li>NCV extremely slowed or absent </li> </ul> </td> </tr> <tr> <td><em>MPZ</em></td> <td>1q23.3</td> </tr> <tr class="divider_bottom"> <td><em>EGR2</em></td> <td>10q21.3</td> </tr> <tr> <td colspan="4"><strong>CMT4</strong></td> </tr> <tr> <td class="indent1">CMT4A</td> <td><em>GDAP1</em></td> <td>8q21.11</td> <td> <ul> <li>Onset in early childhood </li> <li>Distal weakness </li> <li>Mild sensory loss </li> <li>Rapidly progressive </li> <li>Incapacity in first decade </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4B1</td> <td><em>MTMR2</em></td> <td>11q21</td> <td> <ul> <li>Onset at age 2 to 4 years </li> <li>Distal and proximal weakness </li> <li>Moderate sensory loss </li> <li>Frequent involvement of cranial nerves </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4B2</td> <td><em>SBF2</em></td> <td>11p15.4</td> <td> <ul> <li>Onset in first two decades </li> <li>Initial distal weakness </li> <li>Proximal weakness after several years </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4B3</td> <td><em>SBF1</em></td> <td>22q13.33</td> <td> <ul> <li>Onset mean age 8 years </li> <li>Slowly progressive leg weakness and gait difficulty </li> <li>Areflexia and sensory loss (vibration/position affected more than pain/temperature) </li> <li>Pes planus </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4C</td> <td><em>SH3TC2</em></td> <td>5q32</td> <td> <ul> <li>Severe spinal deformities and weakness </li> <li>Onset in childhood and adolescence </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4D</td> <td><em>NDRG1</em></td> <td>8q24.22</td> <td> <ul> <li>Early onset neuropathy </li> <li>Muscle weakness and wasting </li> <li>Skeletal deformities </li> <li>Sensory loss </li> <li>Neural deafness in second or third decade </li> <li>NCV severely reduced </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4E</td> <td><em>EGR2</em></td> <td>10q21.3</td> <td> <ul> <li>Distal weakness at birth </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4F</td> <td><em>PRX</em></td> <td>19q13.2</td> <td> <ul> <li>Onset in early childhood </li> <li>Distal muscle weakness </li> <li>Severe sensory loss </li> <li>Absent sensory and motor evoked response on NCV </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4H</td> <td><em>FGD4</em></td> <td>12p11.21</td> <td> <ul> <li>Severe demyelinating neuropathy </li> <li>Unsteady gait </li> </ul> </td> </tr> <tr> <td class="indent1">CMT4J</td> <td><em>FIG4</em></td> <td>6q21</td> <td> <ul> <li>Childhood or adult onset </li> <li>Widespread denervation </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">NCV: nerve conduction velocity.</div><div id="graphicVersion">Graphic 72688 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
